Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

NCT06372964 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Depression

Interventions

DRUG: Lumateperone
DRUG: Placebo

Sponsor

Intra-Cellular Therapies, Inc.